✦ LIBER ✦

131I therapy in differentiated thyroid carcinoma: M. D. Anderson hospital experience

✍ Scribed by Yugal K. Maheshwari; C. Stratton Hill Jr.; Thomas P. Haynie III.; Robert C. Hickey; Naguib A. Samaan

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 543 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810215)47:4<664::aid-cncr2820470408>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implications of mediastinal uptake of 13

Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma

✍ Jan Willem Haveman; Ha T. T. Phan; Thera P. Links; Piet L. Jager; John T. M. Plu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract ## BACKGROUND Findings of mediastinal uptake of ^131^I after surgical treatment for differentiated thyroid carcinoma (DTC) are common, especially in young patients. Given the frequency of false‐positive findings, a protocol for diagnostic and therapeutic strategies would be useful. Wit

Prognostic value of postsurgical stimula

Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma

✍ Anna M. Sawka; Steven Orlov; Jacob Gelberg; Barry Stork; Mark Dowar; Michael Sha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract ## Background. In well‐differentiated thyroid carcinoma, predictors of future positivity of stimulated thyroglobulin (>2 μg/L) after initial radioactive iodine treatment are not known. ## Methods. In a retrospective study, we used logistic regression analysis to determine whether pos

Synthesis of thyroglobulin in thyroid ca

Synthesis of thyroglobulin in thyroid carcinoma patients after radioiodine therapy

✍ R. K. Jeevanram; D. H. Shah; B. S. Ajay Kumar; S. M. Sharma; R. D. Ganatra 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

Survival rates in patients with differen

Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy

✍ G. Benker; TH. Olbricht; D. Reinwein; Ch R. Reiners; W. Sauerwein; U. Krause; M. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 2 views

Use of I131 labeled fat and fatty acid t

Use of I131 labeled fat and fatty acid to differentiate digestive from absorptive defects in steatorrhea : Ervin Kaplan, M.D., Bernard Edidin, M.D., and Robert Fruin, M.D., Veterans Administration Hospital, Hines, Illinois

📂 Article 📅 1957 🏛 Elsevier Science ⚖ 184 KB

Phase I/II trial of 131I-MN-14 F(ab)2 an

Phase I/II trial of 131I-MN-14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

✍ Malik E. Juweid; George Hajjar; Lawrence C. Swayne; Robert M. Sharkey; Samer Sul 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

## BACKGROUND. Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD), and therapeutic potential of 131 I-MN-14 F(ab